[go: up one dir, main page]

AR016869A1 - Metodo para preparar una suspension farmaceutica acuosa de nevirapina, dicha suspension farmaceutica y uso de nevirapina para preparar dicha suspensionfarmaceutica - Google Patents

Metodo para preparar una suspension farmaceutica acuosa de nevirapina, dicha suspension farmaceutica y uso de nevirapina para preparar dicha suspensionfarmaceutica

Info

Publication number
AR016869A1
AR016869A1 ARP980104200A ARP980104200A AR016869A1 AR 016869 A1 AR016869 A1 AR 016869A1 AR P980104200 A ARP980104200 A AR P980104200A AR P980104200 A ARP980104200 A AR P980104200A AR 016869 A1 AR016869 A1 AR 016869A1
Authority
AR
Argentina
Prior art keywords
pharmaceutical
nevirapine
suspension
prepare
waterproof
Prior art date
Application number
ARP980104200A
Other languages
English (en)
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22006658&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR016869(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of AR016869A1 publication Critical patent/AR016869A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Método para preparar una suspension farmacéutica acuosa de nevirapina que comprende mezclar hemihidrato de nevirapina que tiene un tamano de partículasentre aproximadamente 1 y 150 micrometros, con agua y, discrecionalmente, aditivos farmacéuticosco nvencionales. Suspension farmacéutica que constaesencialmente de hemihidrato de nevirapina que tiene un tamano de partículas entre aproximadamente 1 y 150 micrometros, agua y, discrecionalmente, aditivosfarmacéuticos convencionales. Uso denevirapina para preparar una suspension farmacéutica, la cual contiene hemihidrato de nevirapina y está destinada altratamiento de la infeccion VIH-1.
ARP980104200A 1997-08-25 1998-08-25 Metodo para preparar una suspension farmaceutica acuosa de nevirapina, dicha suspension farmaceutica y uso de nevirapina para preparar dicha suspensionfarmaceutica AR016869A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5680397P 1997-08-25 1997-08-25

Publications (1)

Publication Number Publication Date
AR016869A1 true AR016869A1 (es) 2001-08-01

Family

ID=22006658

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP980104200A AR016869A1 (es) 1997-08-25 1998-08-25 Metodo para preparar una suspension farmaceutica acuosa de nevirapina, dicha suspension farmaceutica y uso de nevirapina para preparar dicha suspensionfarmaceutica
ARP110103815A AR083451A2 (es) 1997-08-25 2011-10-14 Metodo para preparar una suspension farmaceutica acuosa de nevirapina, dicha suspension farmaceutica y uso de nevirapina para preparar dicha suspension farmaceutica

Family Applications After (1)

Application Number Title Priority Date Filing Date
ARP110103815A AR083451A2 (es) 1997-08-25 2011-10-14 Metodo para preparar una suspension farmaceutica acuosa de nevirapina, dicha suspension farmaceutica y uso de nevirapina para preparar dicha suspension farmaceutica

Country Status (37)

Country Link
US (2) US6172059B1 (es)
EP (1) EP1019058B1 (es)
JP (1) JP3472261B2 (es)
KR (1) KR100426516B1 (es)
CN (1) CN1197578C (es)
AR (2) AR016869A1 (es)
AT (1) ATE326971T1 (es)
AU (1) AU742761B2 (es)
BG (1) BG64337B1 (es)
BR (1) BR9811994B1 (es)
CA (1) CA2301646C (es)
CL (1) CL2008003111A1 (es)
CO (1) CO4970742A1 (es)
CY (1) CY1105228T1 (es)
CZ (1) CZ290667B6 (es)
DE (1) DE69834655T2 (es)
DK (1) DK1019058T3 (es)
EG (1) EG24075A (es)
ES (1) ES2265666T3 (es)
HR (1) HRP980461B1 (es)
HU (1) HU226063B1 (es)
ID (1) ID21650A (es)
IL (1) IL134185A (es)
MY (1) MY122272A (es)
NO (1) NO326226B1 (es)
NZ (1) NZ503414A (es)
PE (1) PE105799A1 (es)
PL (1) PL192361B1 (es)
PT (1) PT1019058E (es)
RS (1) RS49808B (es)
RU (1) RU2196584C2 (es)
SA (1) SA98190680B1 (es)
TR (1) TR200000490T2 (es)
TW (1) TW450812B (es)
UA (1) UA44370C2 (es)
WO (1) WO1999009990A1 (es)
ZA (1) ZA987623B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002092095A1 (en) * 2001-05-11 2002-11-21 Boehringer Ingelheim International Gmbh Use of nevirapine to treat or prevent lipid pathology in patients with hiv that is resistant to nevirapine
CA2479943A1 (en) * 2002-04-23 2003-11-06 Boehringer Ingelheim Pharmaceuticals, Inc. Method for reduction of residual organic solvent in carbomer
NZ566796A (en) * 2005-08-31 2011-04-29 Cipla Ltd Pharmaceutical combinations containing lamivudine, stavudine and nevirapine
US20110082161A1 (en) * 2008-06-30 2011-04-07 Lieven Elvire Colette Baert Powders for reconstitution
EP2499141B1 (en) * 2009-11-10 2013-07-24 The North West University Nevirapine polymorph
BR112012014762A2 (pt) * 2009-12-17 2016-03-29 Univ Northwest forma polimorfa de nevirapina e sua preparação

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5366972A (en) 1989-04-20 1994-11-22 Boehringer Ingelheim Pharmaceuticals, Inc. 5,11-dihydro-6H-dipyrido(3,2-B:2',3'-E)(1,4)diazepines and their use in the prevention or treatment of HIV infection
DE69007891T2 (de) * 1989-06-28 1994-08-25 Boehringer Ingelheim Pharma 5,11-Dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one und -thione und ihre Verwendung bei der AIDS-Vorbeugung oder -Behandlung.
CA2030056C (en) * 1989-11-17 1995-10-17 Karl D. Hargrave 5,11-dihydro-6h-dipyrido[3,2-b:2',3'-e][1,4]diazepines and their use in the prevention or treatment of hiv infection
US5571912A (en) * 1990-10-19 1996-11-05 Boehringer Ingelheim Pharmaceuticals, Inc. Method for the preparation of 5,11-dihydro-6h-dipyrido [3,2-b:2',3'-e][1,4]diazepines
GB9215178D0 (en) * 1992-07-16 1992-08-26 Glaxo Group Ltd Antiviral combinations
CA2178760C (en) * 1993-12-15 2000-08-01 Joel R. Huff Hiv protease inhibitors
DE4403311C1 (de) * 1994-02-03 1995-04-20 Boehringer Ingelheim Kg Verfahren zur Herstellung von Nevirapine (11-Cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido[3,2-b:2',3'-e][1,4-diazepin]-6-on)

Also Published As

Publication number Publication date
UA44370C2 (uk) 2002-02-15
CY1105228T1 (el) 2010-03-03
CN1197578C (zh) 2005-04-20
PE105799A1 (es) 1999-11-16
DE69834655D1 (de) 2006-06-29
IL134185A0 (en) 2001-04-30
WO1999009990A1 (en) 1999-03-04
AU8777198A (en) 1999-03-16
AU742761B2 (en) 2002-01-10
EP1019058B1 (en) 2006-05-24
HK1027975A1 (en) 2001-02-02
JP2001513564A (ja) 2001-09-04
IL134185A (en) 2005-11-20
EP1019058A1 (en) 2000-07-19
US6255481B1 (en) 2001-07-03
CA2301646A1 (en) 1999-03-04
NZ503414A (en) 2002-11-26
YU9800A (sh) 2001-12-26
HU226063B1 (hu) 2008-04-28
CZ290667B6 (cs) 2002-09-11
CL2008003111A1 (es) 2009-09-11
KR20010023257A (ko) 2001-03-26
NO20000906L (no) 2000-02-24
DK1019058T3 (da) 2006-06-12
RU2196584C2 (ru) 2003-01-20
DE69834655T2 (de) 2006-12-14
ZA987623B (en) 2000-03-22
TW450812B (en) 2001-08-21
ES2265666T3 (es) 2007-02-16
PT1019058E (pt) 2006-08-31
TR200000490T2 (tr) 2000-08-21
BG104133A (bg) 2000-08-31
BR9811994B1 (pt) 2013-11-19
MY122272A (en) 2006-04-29
HUP0003093A2 (hu) 2001-08-28
ATE326971T1 (de) 2006-06-15
PL192361B1 (pl) 2006-10-31
CA2301646C (en) 2008-11-18
HRP980461A2 (en) 1999-06-30
BR9811994A (pt) 2000-09-05
PL338828A1 (en) 2000-11-20
RS49808B (sr) 2008-08-07
NO326226B1 (no) 2008-10-20
BG64337B1 (bg) 2004-10-29
NO20000906D0 (no) 2000-02-24
AR083451A2 (es) 2013-02-27
ID21650A (id) 1999-07-08
SA98190680B1 (ar) 2006-04-04
CZ2000694A3 (cs) 2000-09-13
HRP980461B1 (en) 2002-08-31
JP3472261B2 (ja) 2003-12-02
US6172059B1 (en) 2001-01-09
KR100426516B1 (ko) 2004-04-13
EP1019058A4 (en) 2004-11-10
EG24075A (en) 2008-05-11
CO4970742A1 (es) 2000-11-07
CN1268055A (zh) 2000-09-27

Similar Documents

Publication Publication Date Title
MX20055A (es) Procedimiento para la preparacion de una composicion acuosa de ibuprofen y procedimiento para su preparacion.
IT1183574B (it) Metodo per ottenere una sospensione estemporanea omogenea di microcapsule
BR9101466A (pt) Catalisador de combustao de oxido complexo de terra rara,processo para preparacao desto catalisador e uso deste catalisador
ATE74003T1 (de) Waessriges pharmazeutisches praeparat.
BR9600926A (pt) Micelas mistas composições aquosas processo para a preparação de micelas mistas e uso
ES2145882T3 (es) Emulsion de agua-en-aceite sin agente tensioactivo.
BR9610089A (pt) Microemulsão não tóxica de óleo em água ou bicontínua processo para sua preparação e uso da mesma
AR025247A1 (es) Composiciones de granulos de carotenos-xantofilos, estables
ES2123800T3 (es) Composicion para el cuidado de la piel que contiene vaselina emulsionada.
AR004357A1 (es) Compuestos de 1-fenil-2-dimetilaminometil-ciclohexan-1-ol, y procedimiento de preparacion para dichos compuestos.
ES2095128T3 (es) Uso de beta-ciclodextrina y un procedimiento para mejorar espesantes para sistemas acuosos.
ES2172572T3 (es) Emulsion farmaceutica.
BR9704554B1 (pt) utilizaÇço de lipÍdios complexos como adiÇÕes de estabilizaÇço para composiÇÕes farmacÊuticas de misturas de enzimas de digestço, composiÇÕes farmacÊuticas soléveis em Água e kit para preparaÇço de soluÇÕes aquosas.
IT8820073A0 (it) Formulazioni farmaceutiche acquose di piroxicam e procedimento per laloro preparazione.
FI873092L (fi) Polymeerihiukkanen sekä sen vesidispersio, valmistusmenetelmä ja käyttö
AR016869A1 (es) Metodo para preparar una suspension farmaceutica acuosa de nevirapina, dicha suspension farmaceutica y uso de nevirapina para preparar dicha suspensionfarmaceutica
BR9903257A (pt) Concentrado de suspensão aquosa contendo tiadiazurona e etefona
BR9916399A (pt) Método para preparar uma vacina auxiliada por emulsão água/óleo inativada, e, conjunto de partes que podem ser usadas para a preparação de uma vacina auxiliada por emulsão água/óleo inativada
FI945427L (fi) Dynemisiinianalogien enantiomeerit, niiden valmistus ja käyttö
ES2105605T3 (es) Antagonistas de taquiquinina, su preparacion y utilizacion en formulaciones farmaceuticas.
BR9400831A (pt) Poliuretanos insaturados, seu uso e dispersões aquosas de resinas alquídicas hidrófobas
EA199900750A1 (ru) Водная фармацевтическая композиция, включающая активный ингредиент, в высшей степени нерастворимый в воде
AR020695A1 (es) Metodos para controlar macroinvertebrados en sistemas acuosos
BR0012006A (pt) Método para evitar inflamações, doenças autoimunes e crescimento de tumor, e, uso de substâncias que suprimem a ativação mediada por ltbr
FI893598A7 (fi) Sekundaarisia polyeetteriamiineja, niiden valmistus ja käyttö polyureajohdannaisten valmistukseen

Legal Events

Date Code Title Description
FC Refusal